Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update

8 Nov 2022 08:09

RNS Number : 6669F
Applied Graphene Materials PLC
08 November 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR"). IN ADDITION, MARKET SOUNDINGS (AS DEFINED IN UK MAR) WERE TAKEN IN RESPECT OF CERTAIN OF THE MATTERS CONTAINED WITHIN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF INSIDE INFORMATION (AS DEFINED UNDER UK MAR). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THOSE PERSONS THAT RECEIVED INSIDE INFORMATION IN A MARKET SOUNDING ARE NO LONGER IN POSSESSION OF SUCH INSIDE INFORMATION, WHICH IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

08 November 2022

Applied Graphene Materials plc

("Applied Graphene Materials", "the Group" or "the Company")

Update

 

The Company's board of directors notes an article published on the ShareProphets website on the evening of 7 November 2022 regarding a possible equity raise.

 

The Board has previously outlined its plans to raise further equity in order to fund the Company's operations and the continued development of the business.

 

The Company has spent recent weeks investigating the feasibility of an equity raise with institutional and other investors and this process is now complete. Having regard to the unfavourable conditions in small-cap equity markets, the Board has concluded that it will not be possible at the current time to complete an equity raise. Whilst the Board is pleased with the start that the Company has made to its new financial year, the Company requires additional funding to extend its cash runway beyond 31 January 2023, which as previously disclosed is the date on which the board expects that the Company's current financial resources will be fully depleted.

 

The Board will provide further updates to shareholders as appropriate.

 

For further information, please contact:

Applied Graphene Materials  +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

Singer Capital Markets  +44 (0) 207 496 3000

Peter Steel / Amanda Gray

Allenby Capital Limited  +44 (0) 203 328 5656

Nick Athanas / George Payne (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

Hudson Sandler +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKFBKFBDKADK
Date   Source Headline
11th Jan 20163:36 pmRNSDirector/PDMR Shareholding
8th Jan 201612:13 pmRNSResult of Meeting
18th Dec 20157:00 amRNSPlacing and Open Offer
16th Nov 20157:00 amRNSFull Year Results
23rd Oct 20157:00 amRNSJoint Development Agreements and Collaborations
21st Sep 20155:19 pmRNSHolding(s) in Company
18th Sep 20157:00 amRNSPeriod end trading update
9th Jul 20157:00 amRNSIssue of share options to Directors
30th Jun 20153:36 pmRNSHolding(s) in Company
17th Jun 20157:00 amRNSFirst Patent Approval
19th May 20154:40 pmRNSSecond Price Monitoring Extn
19th May 20154:35 pmRNSPrice Monitoring Extension
14th May 20157:00 amRNSPositive results from independent oil trials
27th Apr 20159:21 amRNSHolding(s) in Company
22nd Apr 20154:44 pmRNSHolding(s) in Company
22nd Apr 20153:28 pmRNSHolding(s) in Company
21st Apr 20154:46 pmRNSHolding(s) in Company
17th Apr 20157:00 amRNSPositive results from independent coatings trials
2nd Apr 20159:46 amRNSHolding(s) in Company
1st Apr 20154:39 pmRNSHolding(s) in Company
25th Mar 20157:00 amRNSInterim Results
3rd Feb 20157:00 amRNSTrading Update
27th Jan 201511:25 amRNSIssue of equity and total voting rights
22nd Jan 20157:00 amRNSSenior Management Appointments
22nd Dec 20147:00 amRNSDirectorate Change
15th Dec 201411:36 amRNSResult of AGM
15th Dec 20147:00 amRNSAGM Statement
24th Nov 20147:00 amRNSPosting of Annual Report and Notice of AGM
17th Nov 20147:00 amRNSInvestor site visit
5th Nov 20147:00 amRNSAppointment of Non-Executive Director
5th Nov 20147:00 amRNSFull Year Results
5th Sep 20147:00 amRNSPre-close update
28th Jul 20147:00 amRNSIssue of share options to Directors
9th Jul 201410:17 amRNSGrant of Options to Directors
2nd Jul 20144:36 pmRNSHolding(s) in Company
23rd May 20143:08 pmRNSIssue of Share Options
30th Apr 20143:40 pmRNSReplacement - Holding(s) in Company
28th Apr 20148:50 amRNSHolding(s) in Company
1st Apr 20147:00 amRNSAppointment of Non Executive Director
1st Apr 20147:00 amRNSInterim Results
19th Mar 20147:00 amRNSNotice of Interim Results
18th Mar 201411:00 amRNSDirectorate Change
20th Jan 20144:39 pmRNSHolding(s) in Company
15th Jan 201410:59 amRNSIssue of Equity
27th Nov 20134:40 pmRNSSecond Price Monitoring Extn
27th Nov 20134:35 pmRNSPrice Monitoring Extension
26th Nov 20134:40 pmRNSSecond Price Monitoring Extn
26th Nov 20134:35 pmRNSPrice Monitoring Extension
22nd Nov 201312:39 pmRNSHolding(s) in Company
20th Nov 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.